Quantitative Investment Management, LLC Intercept Pharmaceuticals, Inc. Transaction History

Quantitative Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $335,626 - $655,453	-17,363 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $336,893 - $584,472	-13,762 Reduced 44.22%	17,363 $428,000
Q3 2020 Nov 13, 2020	BUY	$39.09 - $53.44 $1.22 Million - $1.66 Million	31,125 New	31,125 $1.29 Million
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $1.58 Million - $3.12 Million	-33,878 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$48.35 - $118.68 $1.64 Million - $4.02 Million	33,878 New	33,878 $2.13 Million

Q3 2018 Nov 14, 2018	SELL	$88.49 - $127.55 $495,544 - $714,280	-5,600 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$60.0 - $85.67 $2.17 Million - $3.09 Million	-36,100 Reduced 86.57%	5,600 $469,000
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $2.2 Million - $2.8 Million	41,700 New	41,700 $2.57 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.